lobbying_filings_raw: 384f7e53-8a23-4e1a-9dc4-df5da1cac110
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 384f7e53-8a23-4e1a-9dc4-df5da1cac110 | Q3 | 313715 | CAPITOL COUNSEL LLC | 184407 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2010 | third_quarter | 2010-10-06T16:03:21.553000-04:00 | 90000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/384f7e53-8a23-4e1a-9dc4-df5da1cac110/", "filing_uuid": "384f7e53-8a23-4e1a-9dc4-df5da1cac110", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2010, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/384f7e53-8a23-4e1a-9dc4-df5da1cac110/print/", "filing_document_content_type": "text/html", "income": "90000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Shannon Finley, Member", "dt_posted": "2010-10-06T16:03:21.553000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "901 15th Street, NW Suite 500", "registrant_address_2": null, "registrant_different_address": true, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 313715, "url": "https://lda.senate.gov/api/v1/registrants/313715/", "house_registrant_id": 39384, "name": "CAPITOL COUNSEL LLC", "description": "Government affairs.", "address_1": "700 13th Street NW, 2nd Floor", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "TRACEY A. GRAY", "contact_telephone": "+1 202-861-3200", "dt_updated": "2026-01-30T14:41:10.487511-05:00"}, "client": {"id": 184407, "url": "https://lda.senate.gov/api/v1/clients/184407/", "client_id": 1004571, "name": "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", "general_description": "Represents pharmaceutical research and biotechnology companies", "client_government_entity": false, "client_self_select": false, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2008-12-01"}, "lobbying_activities": [{"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Pharmaceutical Manufacturer Tax and related provisions in HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 45351, "prefix": null, "prefix_display": null, "first_name": "SHANNON", "nickname": null, "middle_name": null, "last_name": "FINLEY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39065, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": "D", "last_name": "RAFFAELLI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5154, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": null, "last_name": "GOULD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 46973, "prefix": null, "prefix_display": null, "first_name": "TUCKER", "nickname": null, "middle_name": null, "last_name": "SHUMACK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 52257, "prefix": "mr", "prefix_display": "MR.", "first_name": "JAMES", "nickname": null, "middle_name": "O", "last_name": "MCCRERY", "suffix": "iii", "suffix_display": "III"}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Legislative issues related to access to pharmaceuticals, including Medicare Part D, and Children's Health Insurance Program (CHIP), rebates in Medicaid and for dual-eligibles; comparative effectiveness; 340B Drug Program and related provisions in HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 45351, "prefix": null, "prefix_display": null, "first_name": "SHANNON", "nickname": null, "middle_name": null, "last_name": "FINLEY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 52257, "prefix": "mr", "prefix_display": "MR.", "first_name": "JAMES", "nickname": null, "middle_name": "O", "last_name": "MCCRERY", "suffix": "iii", "suffix_display": "III"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39065, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": "D", "last_name": "RAFFAELLI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5154, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": null, "last_name": "GOULD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 49745, "prefix": null, "prefix_display": null, "first_name": "DREW", "nickname": null, "middle_name": null, "last_name": "GOESL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 15011, "prefix": "mr", "prefix_display": "MR.", "first_name": "RICHARD", "nickname": null, "middle_name": "LYLES", "last_name": "SULLIVAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 46973, "prefix": null, "prefix_display": null, "first_name": "TUCKER", "nickname": null, "middle_name": null, "last_name": "SHUMACK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 39384 | DC | US | US | Represents pharmaceutical research and biotechnology companies | 0 | 0 | 993215 | normalized_name_state | 0.9 |